Research Projects & Grants

Federal

• COG AALL1631: International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones, Role: Investigator, Children Oncology Group, (06/2025 - 06/2026) Status: Approved
• COG ACNS1422: A Phase 2 Study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients, Role: Investigator, Children Oncology Group, (05/2025 - 05/2026) Status: Approved

Internal

• Radiation medicine research registry, Role: Investigator, LLU Dept. of Radiation Medicine, (09/2025 - 09/2026) Status: Approved
• Proton radiotherapy for isolated lymph node recurrence in gynecological cancers, Role: Investigator, LLU Dept. of Radiation Medicine, (02/2021) Status: Approved
• Phase II trial of partial breast proton therapy for early stage breast cancer with low and intermediate risk factors, Role: Investigator, LLU Dept. of Radiation Medicine, (08/2025 - 08/2026) Status: Approved
• Phase II trial of lumpectomy and partial breast proton therapy for early stage breast cancer, Role: Investigator, LLU Dept. of Radiation Medicine, (04/2026 - 04/2027) Status: Approved
• Comparative Outcomes of Proton Beam Therapy and Surgery for Vestibular Schwannomas, Role: PI, LLU Dept. of Radiation Medicine, (03/2026) Status: Approved
• Comparative outcomes of pituitary tumor treatments with emphasis on proton beam therapy and hormonal pretreatment, Role: PI, LLU Dept. of Radiation Medicine, (02/2026) Status: Approved